Table of Content

1 Market Overview of Peptide CDMO Services
1.1 Peptide CDMO Services Market Overview
1.1.1 Peptide CDMO Services Product Scope
1.1.2 Peptide CDMO Services Market Status and Outlook
1.2 Global Peptide CDMO Services Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Peptide CDMO Services Market Size by Region (2018-2033)
1.4 Global Peptide CDMO Services Historic Market Size by Region (2018-2023)
1.5 Global Peptide CDMO Services Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Peptide CDMO Services Market Size (2018-2033)
1.6.1 North America Peptide CDMO Services Market Size (2018-2033)
1.6.2 Europe Peptide CDMO Services Market Size (2018-2033)
1.6.3 Asia-Pacific Peptide CDMO Services Market Size (2018-2033)
1.6.4 Latin America Peptide CDMO Services Market Size (2018-2033)
1.6.5 Middle East & Africa Peptide CDMO Services Market Size (2018-2033)
2 Peptide CDMO Services Market by Type
2.1 Introduction
2.1.1 Small Molecule CDMO
2.1.2 Macro-molecular CDMO
2.2 Global Peptide CDMO Services Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Peptide CDMO Services Historic Market Size by Type (2018-2023)
2.2.2 Global Peptide CDMO Services Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Peptide CDMO Services Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Peptide CDMO Services Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Peptide CDMO Services Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Peptide CDMO Services Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Peptide CDMO Services Revenue Breakdown by Type (2018-2033)
3 Peptide CDMO Services Market Overview by Application
3.1 Introduction
3.1.1 Clinical Treatment
3.1.2 Medical Research
3.1.3 Commercial Production
3.2 Global Peptide CDMO Services Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Peptide CDMO Services Historic Market Size by Application (2018-2023)
3.2.2 Global Peptide CDMO Services Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Peptide CDMO Services Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Peptide CDMO Services Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Peptide CDMO Services Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Peptide CDMO Services Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Peptide CDMO Services Revenue Breakdown by Application (2018-2033)
4 Peptide CDMO Services Competition Analysis by Players
4.1 Global Peptide CDMO Services Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide CDMO Services as of 2022)
4.3 Date of Key Players Enter into Peptide CDMO Services Market
4.4 Global Top Players Peptide CDMO Services Headquarters and Area Served
4.5 Key Players Peptide CDMO Services Product Solution and Service
4.6 Competitive Status
4.6.1 Peptide CDMO Services Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Incyte
5.1.1 Incyte Profile
5.1.2 Incyte Main Business
5.1.3 Incyte Peptide CDMO Services Products, Services and Solutions
5.1.4 Incyte Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.1.5 Incyte Recent Developments
5.2 Gliead
5.2.1 Gliead Profile
5.2.2 Gliead Main Business
5.2.3 Gliead Peptide CDMO Services Products, Services and Solutions
5.2.4 Gliead Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.2.5 Gliead Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Profile
5.3.2 Boehringer Ingelheim Main Business
5.3.3 Boehringer Ingelheim Peptide CDMO Services Products, Services and Solutions
5.3.4 Boehringer Ingelheim Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.3.5 Vertex Recent Developments
5.4 Vertex
5.4.1 Vertex Profile
5.4.2 Vertex Main Business
5.4.3 Vertex Peptide CDMO Services Products, Services and Solutions
5.4.4 Vertex Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.4.5 Vertex Recent Developments
5.5 Mirati Therapeutics
5.5.1 Mirati Therapeutics Profile
5.5.2 Mirati Therapeutics Main Business
5.5.3 Mirati Therapeutics Peptide CDMO Services Products, Services and Solutions
5.5.4 Mirati Therapeutics Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.5.5 Mirati Therapeutics Recent Developments
5.6 AMPAC
5.6.1 AMPAC Profile
5.6.2 AMPAC Main Business
5.6.3 AMPAC Peptide CDMO Services Products, Services and Solutions
5.6.4 AMPAC Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.6.5 AMPAC Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer Peptide CDMO Services Products, Services and Solutions
5.7.4 Pfizer Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer Recent Developments
5.8 Polypeptide
5.8.1 Polypeptide Profile
5.8.2 Polypeptide Main Business
5.8.3 Polypeptide Peptide CDMO Services Products, Services and Solutions
5.8.4 Polypeptide Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.8.5 Polypeptide Recent Developments
5.9 Bachem
5.9.1 Bachem Profile
5.9.2 Bachem Main Business
5.9.3 Bachem Peptide CDMO Services Products, Services and Solutions
5.9.4 Bachem Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.9.5 Bachem Recent Developments
5.10 Merck
5.10.1 Merck Profile
5.10.2 Merck Main Business
5.10.3 Merck Peptide CDMO Services Products, Services and Solutions
5.10.4 Merck Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.10.5 Merck Recent Developments
5.11 Asymchem
5.11.1 Asymchem Profile
5.11.2 Asymchem Main Business
5.11.3 Asymchem Peptide CDMO Services Products, Services and Solutions
5.11.4 Asymchem Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.11.5 Asymchem Recent Developments
5.12 Zhejiang Jiuzhou Pharmaceutical
5.12.1 Zhejiang Jiuzhou Pharmaceutical Profile
5.12.2 Zhejiang Jiuzhou Pharmaceutical Main Business
5.12.3 Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Products, Services and Solutions
5.12.4 Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
5.13 Sinopep
5.13.1 Sinopep Profile
5.13.2 Sinopep Main Business
5.13.3 Sinopep Peptide CDMO Services Products, Services and Solutions
5.13.4 Sinopep Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.13.5 Sinopep Recent Developments
5.14 Frontier Biotechnologies
5.14.1 Frontier Biotechnologies Profile
5.14.2 Frontier Biotechnologies Main Business
5.14.3 Frontier Biotechnologies Peptide CDMO Services Products, Services and Solutions
5.14.4 Frontier Biotechnologies Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.14.5 Frontier Biotechnologies Recent Developments
5.15 JYMed
5.15.1 JYMed Profile
5.15.2 JYMed Main Business
5.15.3 JYMed Peptide CDMO Services Products, Services and Solutions
5.15.4 JYMed Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.15.5 JYMed Recent Developments
5.16 Chengdu Shengnuo Biotechnology
5.16.1 Chengdu Shengnuo Biotechnology Profile
5.16.2 Chengdu Shengnuo Biotechnology Main Business
5.16.3 Chengdu Shengnuo Biotechnology Peptide CDMO Services Products, Services and Solutions
5.16.4 Chengdu Shengnuo Biotechnology Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.16.5 Chengdu Shengnuo Biotechnology Recent Developments
5.17 Shanghai Soho-Yiming Pharmaceuticals
5.17.1 Shanghai Soho-Yiming Pharmaceuticals Profile
5.17.2 Shanghai Soho-Yiming Pharmaceuticals Main Business
5.17.3 Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Products, Services and Solutions
5.17.4 Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.17.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
5.18 Chinese Peptide Company
5.18.1 Chinese Peptide Company Profile
5.18.2 Chinese Peptide Company Main Business
5.18.3 Chinese Peptide Company Peptide CDMO Services Products, Services and Solutions
5.18.4 Chinese Peptide Company Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.18.5 Chinese Peptide Company Recent Developments
5.19 Ambio Pharmaceuticals
5.19.1 Ambio Pharmaceuticals Profile
5.19.2 Ambio Pharmaceuticals Main Business
5.19.3 Ambio Pharmaceuticals Peptide CDMO Services Products, Services and Solutions
5.19.4 Ambio Pharmaceuticals Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.19.5 Ambio Pharmaceuticals Recent Developments
5.20 Zhejiang Peptites Biotech
5.20.1 Zhejiang Peptites Biotech Profile
5.20.2 Zhejiang Peptites Biotech Main Business
5.20.3 Zhejiang Peptites Biotech Peptide CDMO Services Products, Services and Solutions
5.20.4 Zhejiang Peptites Biotech Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.20.5 Zhejiang Peptites Biotech Recent Developments
5.21 STA Pharmaceutical
5.21.1 STA Pharmaceutical Profile
5.21.2 STA Pharmaceutical Main Business
5.21.3 STA Pharmaceutical Peptide CDMO Services Products, Services and Solutions
5.21.4 STA Pharmaceutical Peptide CDMO Services Revenue (US$ Million) & (2018-2023)
5.21.5 STA Pharmaceutical Recent Developments
6 North America
6.1 North America Peptide CDMO Services Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Peptide CDMO Services Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Peptide CDMO Services Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Peptide CDMO Services Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Peptide CDMO Services Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Peptide CDMO Services Market Dynamics
11.1 Peptide CDMO Services Industry Trends
11.2 Peptide CDMO Services Market Drivers
11.3 Peptide CDMO Services Market Challenges
11.4 Peptide CDMO Services Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Peptide CDMO Services Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Peptide CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Peptide CDMO Services Market Size Share by Region (2018-2023)
Table 4. Global Peptide CDMO Services Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Peptide CDMO Services Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Peptide CDMO Services Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Peptide CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Peptide CDMO Services Revenue Market Share by Type (2018-2023)
Table 9. Global Peptide CDMO Services Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Peptide CDMO Services Revenue Market Share by Type (2024-2033)
Table 11. North America Peptide CDMO Services Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Peptide CDMO Services Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Peptide CDMO Services Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Peptide CDMO Services Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Peptide CDMO Services Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Peptide CDMO Services Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Peptide CDMO Services Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Peptide CDMO Services Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Peptide CDMO Services Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Peptide CDMO Services Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Peptide CDMO Services Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Peptide CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Peptide CDMO Services Revenue Market Share by Application (2018-2023)
Table 24. Global Peptide CDMO Services Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Peptide CDMO Services Revenue Market Share by Application (2024-2033)
Table 26. North America Peptide CDMO Services Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Peptide CDMO Services Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Peptide CDMO Services Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Peptide CDMO Services Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Peptide CDMO Services Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Peptide CDMO Services Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Peptide CDMO Services Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Peptide CDMO Services Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Peptide CDMO Services Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Peptide CDMO Services Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Peptide CDMO Services Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Peptide CDMO Services Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide CDMO Services as of 2022)
Table 39. Date of Key Players Enter into Peptide CDMO Services Market
Table 40. Global Peptide CDMO Services Key Players Headquarters and Area Served
Table 41. Peptide CDMO Services Product Solution and Service
Table 42. Global Peptide CDMO Services Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Incyte Basic Information List
Table 45. Incyte Description and Business Overview
Table 46. Incyte Peptide CDMO Services Products, Services and Solutions
Table 47. Revenue (US$ Million) in Peptide CDMO Services Business of Incyte (2018-2023)
Table 48. Incyte Recent Developments
Table 49. Gliead Basic Information List
Table 50. Gliead Description and Business Overview
Table 51. Gliead Peptide CDMO Services Products, Services and Solutions
Table 52. Revenue (US$ Million) in Peptide CDMO Services Business of Gliead (2018-2023)
Table 53. Gliead Recent Developments
Table 54. Boehringer Ingelheim Basic Information List
Table 55. Boehringer Ingelheim Description and Business Overview
Table 56. Boehringer Ingelheim Peptide CDMO Services Products, Services and Solutions
Table 57. Revenue (US$ Million) in Peptide CDMO Services Business of Boehringer Ingelheim (2018-2023)
Table 58. Boehringer Ingelheim Recent Developments
Table 59. Vertex Basic Information List
Table 60. Vertex Description and Business Overview
Table 61. Vertex Peptide CDMO Services Products, Services and Solutions
Table 62. Revenue (US$ Million) in Peptide CDMO Services Business of Vertex (2018-2023)
Table 63. Vertex Recent Developments
Table 64. Mirati Therapeutics Basic Information List
Table 65. Mirati Therapeutics Description and Business Overview
Table 66. Mirati Therapeutics Peptide CDMO Services Products, Services and Solutions
Table 67. Revenue (US$ Million) in Peptide CDMO Services Business of Mirati Therapeutics (2018-2023)
Table 68. Mirati Therapeutics Recent Developments
Table 69. AMPAC Basic Information List
Table 70. AMPAC Description and Business Overview
Table 71. AMPAC Peptide CDMO Services Products, Services and Solutions
Table 72. Revenue (US$ Million) in Peptide CDMO Services Business of AMPAC (2018-2023)
Table 73. AMPAC Recent Developments
Table 74. Pfizer Basic Information List
Table 75. Pfizer Description and Business Overview
Table 76. Pfizer Peptide CDMO Services Products, Services and Solutions
Table 77. Revenue (US$ Million) in Peptide CDMO Services Business of Pfizer (2018-2023)
Table 78. Pfizer Recent Developments
Table 79. Polypeptide Basic Information List
Table 80. Polypeptide Description and Business Overview
Table 81. Polypeptide Peptide CDMO Services Products, Services and Solutions
Table 82. Revenue (US$ Million) in Peptide CDMO Services Business of Polypeptide (2018-2023)
Table 83. Polypeptide Recent Developments
Table 84. Bachem Basic Information List
Table 85. Bachem Description and Business Overview
Table 86. Bachem Peptide CDMO Services Products, Services and Solutions
Table 87. Revenue (US$ Million) in Peptide CDMO Services Business of Bachem (2018-2023)
Table 88. Bachem Recent Developments
Table 89. Merck Basic Information List
Table 90. Merck Description and Business Overview
Table 91. Merck Peptide CDMO Services Products, Services and Solutions
Table 92. Revenue (US$ Million) in Peptide CDMO Services Business of Merck (2018-2023)
Table 93. Merck Recent Developments
Table 94. Asymchem Basic Information List
Table 95. Asymchem Description and Business Overview
Table 96. Asymchem Peptide CDMO Services Products, Services and Solutions
Table 97. Revenue (US$ Million) in Peptide CDMO Services Business of Asymchem (2018-2023)
Table 98. Asymchem Recent Developments
Table 99. Zhejiang Jiuzhou Pharmaceutical Basic Information List
Table 100. Zhejiang Jiuzhou Pharmaceutical Description and Business Overview
Table 101. Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Products, Services and Solutions
Table 102. Revenue (US$ Million) in Peptide CDMO Services Business of Zhejiang Jiuzhou Pharmaceutical (2018-2023)
Table 103. Zhejiang Jiuzhou Pharmaceutical Recent Developments
Table 104. Sinopep Basic Information List
Table 105. Sinopep Description and Business Overview
Table 106. Sinopep Peptide CDMO Services Products, Services and Solutions
Table 107. Revenue (US$ Million) in Peptide CDMO Services Business of Sinopep (2018-2023)
Table 108. Sinopep Recent Developments
Table 109. Frontier Biotechnologies Basic Information List
Table 110. Frontier Biotechnologies Description and Business Overview
Table 111. Frontier Biotechnologies Peptide CDMO Services Products, Services and Solutions
Table 112. Revenue (US$ Million) in Peptide CDMO Services Business of Frontier Biotechnologies (2018-2023)
Table 113. Frontier Biotechnologies Recent Developments
Table 114. JYMed Basic Information List
Table 115. JYMed Description and Business Overview
Table 116. JYMed Peptide CDMO Services Products, Services and Solutions
Table 117. Revenue (US$ Million) in Peptide CDMO Services Business of JYMed (2018-2023)
Table 118. JYMed Recent Developments
Table 119. Chengdu Shengnuo Biotechnology Basic Information List
Table 120. Chengdu Shengnuo Biotechnology Description and Business Overview
Table 121. Chengdu Shengnuo Biotechnology Peptide CDMO Services Products, Services and Solutions
Table 122. Revenue (US$ Million) in Peptide CDMO Services Business of Chengdu Shengnuo Biotechnology (2018-2023)
Table 123. Chengdu Shengnuo Biotechnology Recent Developments
Table 124. Shanghai Soho-Yiming Pharmaceuticals Basic Information List
Table 125. Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview
Table 126. Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Products, Services and Solutions
Table 127. Revenue (US$ Million) in Peptide CDMO Services Business of Shanghai Soho-Yiming Pharmaceuticals (2018-2023)
Table 128. Shanghai Soho-Yiming Pharmaceuticals Recent Developments
Table 129. Chinese Peptide Company Basic Information List
Table 130. Chinese Peptide Company Description and Business Overview
Table 131. Chinese Peptide Company Peptide CDMO Services Products, Services and Solutions
Table 132. Revenue (US$ Million) in Peptide CDMO Services Business of Chinese Peptide Company (2018-2023)
Table 133. Chinese Peptide Company Recent Developments
Table 134. Ambio Pharmaceuticals Basic Information List
Table 135. Ambio Pharmaceuticals Description and Business Overview
Table 136. Ambio Pharmaceuticals Peptide CDMO Services Products, Services and Solutions
Table 137. Revenue (US$ Million) in Peptide CDMO Services Business of Ambio Pharmaceuticals (2018-2023)
Table 138. Ambio Pharmaceuticals Recent Developments
Table 139. Zhejiang Peptites Biotech Basic Information List
Table 140. Zhejiang Peptites Biotech Description and Business Overview
Table 141. Zhejiang Peptites Biotech Peptide CDMO Services Products, Services and Solutions
Table 142. Revenue (US$ Million) in Peptide CDMO Services Business of Zhejiang Peptites Biotech (2018-2023)
Table 143. Zhejiang Peptites Biotech Recent Developments
Table 144. STA Pharmaceutical Basic Information List
Table 145. STA Pharmaceutical Description and Business Overview
Table 146. STA Pharmaceutical Peptide CDMO Services Products, Services and Solutions
Table 147. Revenue (US$ Million) in Peptide CDMO Services Business of STA Pharmaceutical (2018-2023)
Table 148. STA Pharmaceutical Recent Developments
Table 149. North America Peptide CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 150. North America Peptide CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 151. Europe Peptide CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 152. Europe Peptide CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 153. Asia-Pacific Peptide CDMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 154. Asia-Pacific Peptide CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 155. Asia-Pacific Peptide CDMO Services Market Size by Region (2024-2033) & (US$ Million)
Table 156. Asia-Pacific Peptide CDMO Services Market Share by Region (2018-2023)
Table 157. Asia-Pacific Peptide CDMO Services Market Share by Region (2024-2033)
Table 158. Latin America Peptide CDMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 159. Latin America Peptide CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 160. Latin America Peptide CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 161. Middle East & Africa Peptide CDMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 162. Middle East & Africa Peptide CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 163. Middle East & Africa Peptide CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 164. Peptide CDMO Services Market Trends
Table 165. Peptide CDMO Services Market Drivers
Table 166. Peptide CDMO Services Market Challenges
Table 167. Peptide CDMO Services Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide CDMO Services Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Peptide CDMO Services Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Peptide CDMO Services Market Share by Regions: 2022 VS 2033
Figure 4. Global Peptide CDMO Services Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Small Molecule CDMO
Figure 11. Global Small Molecule CDMO Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Macro-molecular CDMO
Figure 13. Global Macro-molecular CDMO Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Peptide CDMO Services Market Size Share by Type: 2022 & 2033
Figure 15. North America Peptide CDMO Services Revenue Market Share by Type (2018-2033)
Figure 16. Europe Peptide CDMO Services Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Peptide CDMO Services Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Peptide CDMO Services Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Peptide CDMO Services Revenue Market Share by Type (2018-2033)
Figure 20. Clinical Treatment Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Medical Research Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Commercial Production Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Global Peptide CDMO Services Market Size Share by Application: 2022 & 2033
Figure 24. North America Peptide CDMO Services Revenue Market Share by Application (2018-2033)
Figure 25. Europe Peptide CDMO Services Revenue Market Share by Application (2018-2033)
Figure 26. Asia-Pacific Peptide CDMO Services Revenue Market Share by Application (2018-2033)
Figure 27. Latin America Peptide CDMO Services Revenue Market Share by Application (2018-2033)
Figure 28. Middle East and Africa Peptide CDMO Services Revenue Market Share by Application (2018-2033)
Figure 29. Peptide CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Peptide CDMO Services Market Share in 2022
Figure 31. North America Peptide CDMO Services Market Share by Country (2018-2033)
Figure 32. United States Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 33. Canada Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 34. Germany Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 35. France Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 36. U.K. Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 37. Italy Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 38. Russia Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 39. Nordic Countries Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 40. Asia-Pacific Peptide CDMO Services Market Share by Region (2018-2033)
Figure 41. China Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 42. Japan Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 43. South Korea Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 45. India Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 46. Australia Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 47. Latin America Peptide CDMO Services Market Share by Country (2018-2033)
Figure 48. Mexico Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 49. Brazil Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Peptide CDMO Services Market Share by Country (2018-2033)
Figure 51. Turkey Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 53. UAE Peptide CDMO Services Market Size (2018-2033) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report